Merck Secures Exclusive License for Oral Lipoprotein(a) Inhibitor; Tiziana Life Sciences Advances MS Clinical Trial 1 year ago JohnIn Clinical TrialsDealsInnovationPharma Industry UpdatesResearch Updates
Abbott Launches TECTONIC Clinical Trial for Novel Coronary Artery Disease Treatment 1 year ago JohnIn Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
PDC*line Pharma Unveils Promising Lung Cancer Vaccine Data at European Congress 1 year ago JohnIn Deals
Digital Health and Advanced Manufacturing Drive Biopharma Innovation and Efficiency 1 year ago JohnIn AI & DataBiopharma ManufacturingTechnology
Alnylam’s Vutrisiran Gains FDA Approval for Transthyretin Amyloidosis with Cardiomyopathy 1 year ago JohnIn Clinical TrialsFDA ApprovalsInnovation
Novartis Wins FDA Approval for Fabhalta as First and Only Oral Therapy for C3 Glomerulopathy 1 year ago JohnIn Clinical TrialsFDA ApprovalsInnovationTop Stories
FDA Clears First In Vivo Gene-Editing Therapy Trial for Chronic Hepatitis B in the US 1 year ago JohnIn Clinical TrialsFDA ApprovalsInnovationTop Stories
MaaT Pharma Announces Pivotal Phase 3 Success for Microbiome Therapy in Graft-versus-Host Disease 1 year ago JohnIn Clinical TrialsInnovationResearch Updates
Taiho Pharmaceutical Acquires Araris Biotech to Accelerate Next-Generation ADC Drug Development 1 year ago JohnIn InnovationPartnershipsPharma Industry UpdatesResearch Updates
Roche Presents Five-Year Data for SMA and Duchenne, Underscoring Impact of Gene and RNA Therapies 1 year ago JohnIn Biopharma HighlightsClinical TrialsInnovationTop Stories
Gilead Sciences Announces Breakthrough Data for Next-Generation HIV Therapy 1 year ago JohnIn Biopharma HighlightsClinical TrialsInnovationResearch Updates
Regeneron and Sanofi Expand Immunology Pipeline with Novel Monoclonal Antibody Acquisition 1 year ago JohnIn Clinical TrialsInnovationPartnershipsPharma Industry Updates
Amgen’s New Studies Highlight Progress in Cardiovascular and Oncology Areas 1 year ago JohnIn InnovationPartnershipsPharma Industry Updates
Novo Nordisk and Regeneron Lead March with Groundbreaking Obesity and Cardiovascular Therapy Updates 1 year ago JohnIn Clinical TrialsPartnershipsPharma Industry UpdatesResearch Updates
Breakthroughs in Rare Disease Therapies and AI-Enabled Drug Discovery Mark March Biopharma News 1 year ago JohnIn InnovationPartnershipsResearch Updates
